Adenoviral Keratoconjunctivitis Clinical Trial
Official title:
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
Povidone-iodine 2% eye drop versus artificial tear drop for treatment of adenoviral keratoconjunctivitis
Diagnosed EKC patients will be devided into two groups,first group will undergo povidone-iodine 2% eye drop four times a day and the control group will be treated only by artificial tear drops,they will be examined 3 months later and evaluations and data collections for the final comparison will be done. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04417244 -
Adenovirus Keratoconjunctivitis and Ophtalmology
|
||
| Active, not recruiting |
NCT05123014 -
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
|
N/A | |
| Completed |
NCT04376970 -
Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis
|
Phase 4 |